Background: Better and more rapid tests are needed for the diagnosis of tuberculous pleural effusion (TPE), given the known limitations of conventional diagnostic tests. Objectives: To estimate diagnostic accuracy of the QuantiFERON-TB Gold In-Tube (QFT-GIT) test (and its components) using data-derived cutoffs in pleural fluid. Methods: The QFT-GIT test was performed on whole blood and pleural fluid from 43 patients with TPE and 29 control subjects (non-TPE). To achieve the objective, QFT-GIT test, estimating likelihood ratios and receiver operating curve analysis were performed. Results: The sensitivity and specificity using the QFT-GIT for the diagnosis of TPE were 48.8% and 79.3%, respectively, in pleural fluid. The best cutoff points for tuberculosis (TB) antigen, nil and TB antigen minus nil results were estimated at 0.70, 0.90 and 0.30 IU/ml, respectively. Area under the curve of TB antigen IFN-γ response was 0.86 (CI: 0.76–0.93), nil tube was 0.80 (CI: 0.69–0.89) and TB antigen minus nil tube was 0.82 (CI: 0.72–0.90). When the best cutoff scores of the nil tubes were set at this value, the results of a likelihood ratio of a positive and a negative test were 9.44 (7.4–12.0) and 0.37 (0.09–1.5), respectively. The percentages of indeterminate results in pleural fluid among the TPE cases were 42% (most of them caused by high nil IFN-γ values) using the QFT-GIT test. Conclusion: QFT-GIT test or its components have poor accuracy in the diagnosis of TPE, largely because of a high number of indeterminate results due to high background IFN-γ production in the TPE.

Keywords:
Pleurisy, QuantiFERON, T cell IFN-γ release assay, Tuberculosis
1.
Light RW: Pleural effusion. N Engl J Med 2002;346:1971–1977.
2.
Valdés L, Alvarez D, Valle JM, Pose A, San José E: The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996;109:158–162.
3.
Jiang J, Shi HZ, Liang QL, et al: Diagnostic value of interferon-γ in tuberculous pleurisy: a meta-analysis. Chest 2007;131:1133–1141.
4.
Valdés L, Alvarez D, San José E, et al: Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998;158:2017–2021.
5.
Escudero Bueno C, García Clemente M, Cuesta Castro B, et al: Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope’s needle. Study of 414 patients. Arch Intern Med 1990;150:1190–1194.
6.
Valdés L, Pose A, San José E, et al: Tuberculous pleural effusions. Eur J Intern Med 2003;14:77–88.
7.
Liang QL, Shi HZ, Wang K, et al: Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008;102:744–754.
8.
Greco S, Girardi E, Masciangelo R, et al: Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003;7:777–786.
9.
Villena V, López-Encuentra A, Pozo F, et al: Interferon γ levels in pleural fluid for diagnosis of tuberculous. Am J Med 2003;115:365–370.
10.
Sharma SK, Banga A: Diagnostic utility of pleural fluid IFN-γ in tuberculosis pleural effusion. J Interferon Cytokine Res 2004;24:213–217.
11.
North RJ, Jung YJ: Immunity to tuberculosis. Annu Rev Immunol 2004;22:599–623.
12.
Sharma SK, Mitra DK, Balamurugan A, et al: Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 2002;22:345–352.
13.
Mitra DK, Sharma SK, Dinda AK, et al: Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur J Immunol 2005;35:2367–2375.
14.
Wilkinson KA, Wilkinson RJ, Pathan A, et al: Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005;40:184–187.
15.
Losi M, Bossink A, Codecasa L: Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007;30:1173–1179.
16.
Mazurek GH, Jereb J, Lobue P: Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49–55.
17.
Pai M, Menzies D: Interferon-γ release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007;44:74–77.
18.
Pai M, Riley LW, Colford JM: Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–776.
19.
Dheda K, Smit RZ, Badri M, et al: T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009;15:188–200.
20.
Joshi R, Pai M: Can pleural tuberculosis be diagnosed using interferon-γ release assays? Respiration 2008;76:128–130.
21.
QuantiFERON-TB Gold In Tube (package insert). http://www.cellestis.com/IRM/Company/ShowPage.aspx?CPID=1023 (accessed July 2009).
22.
Ariga H, Kawabe Y, Nagai H, et al: Diagnosis of active tuberculous serositis by antigen-specific interferon-γ response of cavity fluid cells. Clin Infect Dis 2007;45:1559–1567.
23.
Chegoua NN, Walzla G, Bolligerb CT, Diaconb AH, Heuvelb MM: Evaluation of adapted whole-blood interferon-γ release assays for the diagnosis of pleural tuberculosis. Respiration 2008;76:131–138.
24.
Sohn Y, Yang D, Huh J, et al: Usefulness of Quantiferon-TB as a diagnostic tool to detect pleural tuberculosis. Chest 2005;128:396S.
25.
Baba K, Sørnes S, Hoosen AA, et al: Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON® TB-Gold interferon-gamma assay. BMC Infect Dis 2008;14;8–35.
26.
Wong CF, Yew WW, Leung SK, et al: Assay of pleural fluid interleukin-6, tumour necrosis factor-α and interferon-γ in the diagnosis and outcome correlation of tuberculous effusion. Respir Med 2003;97:1289–1295.
27.
Dheda K, van Zyl-Smit RN, Sechi LA, et al: Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis. Eur Respir J 2009;34:1118–1126.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.